1994
DOI: 10.1017/s0022215100127045
|View full text |Cite
|
Sign up to set email alerts
|

Post-irradiation carcinosarcoma of the parotid gland

Abstract: Carcinosarcoma of the salivary glands are rare tumours, often associated with a history of pleomorphic adenoma. A case of carcinosarcoma of the parotid arising following irradiation to the resection site of a pleomorphic adenoma is presented. The clinical and histological features are discussed and the literature reviewed.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
15
0

Year Published

1999
1999
2023
2023

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(16 citation statements)
references
References 5 publications
1
15
0
Order By: Relevance
“…36 Radiation-induced transformation or progression of salivary gland tumors to a higher grade has been reported infrequently. [37][38][39] Non-radiation-related "dedifferentiation" of salivary gland tumors is also an uncommon phenomenon. 40,41 Whether histologic progression in the 2 cases we report was related to treatment with radiation is unclear.…”
Section: Casementioning
confidence: 99%
“…36 Radiation-induced transformation or progression of salivary gland tumors to a higher grade has been reported infrequently. [37][38][39] Non-radiation-related "dedifferentiation" of salivary gland tumors is also an uncommon phenomenon. 40,41 Whether histologic progression in the 2 cases we report was related to treatment with radiation is unclear.…”
Section: Casementioning
confidence: 99%
“…14,15 A history of exposure to irradiation of pleomorphic adenoma has been reported as a cause. 16,17 The reported interval between the irradiation and the onset of carcinosarcoma varies from 1 to 36 years.…”
Section: Theories Of Origin Of the Lesionmentioning
confidence: 99%
“…Thus, TMMT is not a collision of separate entities, but might be a tumour with various differentiated components of a pluripotent precursor lesion. A few authors have discussed other points of view 2,11 , 12 . They interpret the various immunohistochemical results in tumour subsets as evidence of their different origin 11,13 .…”
Section: Immunohistochemistry In Components Of True Malignant Mixed mentioning
confidence: 99%
“…A few authors have discussed other points of view. 2,11,12 They interpret the various immunohistochemical results in tumour subsets as evidence of their different origin. 11,13 However, immunohistochemical analysis alone does not allow a b 15,16 losses of chromosome 18 as seen in our case have also been reported.…”
Section: Sirmentioning
confidence: 99%